Mathieu Uzzan

Dr. Mathieu Uzzan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
HGHannah Gordon
Hannah Gordon
JBJohan Burisch
Johan Burisch
PEPierre Ellul
Pierre Ellul
KKKonstantinos Karmiris
Konstantinos Karmiris
KKKonstantinos Katsanos
Konstantinos Katsanos
TKTorsten Kucharzik
Torsten Kucharzik
Hannah Gordon, Johan Burisch, Pierre Ellul, Konstantinos Karmiris, Konstantinos Katsanos, Mariangela Allocca, Giorgos Bamias, Manuel Barreiro-de Acosta, Tasanee

21 February 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MUMathieu Uzzan
Mathieu Uzzan
JMJérôme Martin
Jérôme Martin
LMLuka Mesin
Luka Mesin
ALAlexandra E. Livanos
Alexandra E. Livanos
TCTomas Castro-Dopico
Tomas Castro-Dopico
SMSaurabh Mehandru
Saurabh Mehandru

29 April 2019 in Gut
Verified
Journal Article
Closed access
PDF file
JTJoana Torres
Joana Torres
JHJianzhong Hu
Jianzhong Hu
ASAkihiro Seki
Akihiro Seki
CECaroline Eisele
Caroline Eisele
NNNilendra Nair
Nilendra Nair
IPInga Peter
Inga Peter
Background and aims: Prenatal and early life bacterial colonisation is thought to play a major role in shaping the immune system. Furthermore, accumulating evidence links early life exposures to the risk of developing IBD later in life. We aimed to assess the effect of maternal IBD on the composition of the microbiome during pregnancy and on the offspring’s microbiome. Methods: We prospectively examined the diversity and taxonomy of the microbiome of pregnant women with and without IBD and their babies at multiple time points. We evaluated the role of maternal IBD diagnosis, the mode of delivery, antibiotic use and feeding behaviour on the microbiome composition during early life. To assess the effects of IBD-associated maternal and infant microbiota on the enteric immune system, we inoculated germ-free mice (GFM) with the respective stool and profiled adaptive and innate immune cell populations in the murine intestines. Results: Pregnant women with IBD and their offspring presented with lower bacterial diversity and altered bacterial composition compared with control women and their babies. Maternal IBD was the main predictor of the microbiota diversity in the infant gut at 7, 14, 30, 60 and 90 days of life. Babies born to mothers with IBD demonstrated enrichment in Gammaproteobacteria and depletion in Bifidobacteria. Finally, GFM inoculated with third trimester IBD mother and 90-day infant stools showed significantly reduced microbial diversity and fewer class-switched memory B cells and regulatory T cells in the colon. Conclusion: Aberrant gut microbiota composition persists during pregnancy with IBD and alters the bacterial diversity and abundance in the infant stool. The dysbiotic microbiota triggered abnormal imprinting of the intestinal immune system in GFM.

3 July 2025 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
TKTorsten Kucharzik
Torsten Kucharzik
STStuart Taylor
Stuart Taylor
MAMariangela Allocca
Mariangela Allocca
JBJohan Burisch
Johan Burisch
PEPierre Ellul
Pierre Ellul
RFRoger Feakins
Roger Feakins
The current consensus guideline offers a comprehensive and practical guidance on the diagnostic and monitoring of patients with inflammatory bowel disease (IBD). It provides recommendations on requirements for initial diagnosis, detection of complications, the use of monitoring tools in patients with IBD and diagnostics in specific situations, such as pregnancy, postoperatively and for cancer surveillance. The guideline is a joint project of the European Crohn’s and Colitis Organization (ECCO), the European Society of Gastrointestinal and Abdominal Radiology, the European Society of Pathology, and the International Bowel Ultrasonography Group under the leadership of ECCO.

3 July 2020 in Science Immunology
Verified
Journal Article
Closed access
EGE. K. Grasset
E. K. Grasset
ACA. Chorny
A. Chorny
SCS. Casas-Recasens
S. Casas-Recasens
CGC. Gutzeit
C. Gutzeit
GBG. Bongers
G. Bongers
ACA. Cerutti
A. Cerutti
Signaling by the B cell–activating receptor TACI drives T cell–independent IgA responses to gut commensal bacteria.

3 October 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
MUMathieu Uzzan
Mathieu Uzzan
MTMinami Tokuyama
Minami Tokuyama
ARAdam K. Rosenstein
Adam K. Rosenstein
CTCostin Tomescu
Costin Tomescu
ISIvo SahBandar
Ivo SahBandar
SMSaurabh Mehandru
Saurabh Mehandru
Anti-α4β7 integrin therapy results in attrition of lymphoid aggregates within the gastrointestinal tract of HIV-1–infected individuals with IBD.